Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
about
Urinary tract infections in older women: a clinical reviewSafety and efficacy of long-term outpatient ertapenem therapy.Rapid detection of extended-spectrum-β-lactamase-producing enterobacteriaceae from urine samples by use of the ESBL NDP test.Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.Clinical Efficacy of Ertapenem for Recurrent Cystitis Caused by Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli in Female OutpatientsManagement of complicated urinary tract infections in the era of antimicrobial resistance.Should alternatives to conventional hospitalisation be promoted in an era of financial constraint?Clinical and economic implications of urinary tract infections.Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections.Outpatient parenteral antimicrobial therapy.Differential characteristics of healthcare-associated compared to community-acquired febrile urinary tract infections in males.Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.In Vitro Activities of Ertapenem and Imipenem against Clinical Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae Collected in Military Teaching Hospital Mohammed V of Rabat.Clinical effect of discordance in empirical treatment of cases with urinary tract infection accompanied by bacteremia.Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Efficacy and Cost Comparison of Ertapenem as Outpatient Parenteral Antimicrobial Therapy in Acute Pyelonephritis due to Extended-spectrum Beta-lactamase-producing
P2860
Q27002570-95E6DAB8-CA9D-4D57-A860-DCF8FC99D872Q33798075-DCEEA012-1C97-4390-8286-3150B4CA15B7Q34298270-6AB00323-453D-4DAA-96D7-C8B3225403CFQ35867313-D3210A6D-E3ED-4624-872A-79ABFD66B71CQ36087129-1125B11A-4C61-4E40-A05A-AD5A72A786A7Q36461121-6AA9E5A0-2C7A-4A22-8AFD-1ADDBDE009B9Q37705545-D384C0EA-27B0-4F5C-99B7-2E31A79FCAFDQ37810405-51433E51-C77E-4CB4-945D-A0F174681EA3Q38099412-AF86E19C-EE89-4DCD-8888-B4F70E0B741FQ39450080-1325BE82-6B1F-4119-ABE0-A448284C5A4BQ39726288-21CFF978-C34D-4D63-971D-EF796AF2B35AQ39938810-50CEFF43-E157-4FEF-A2FC-6B6D0F19F536Q40500219-43C1B42C-6913-483F-9F39-0AD28977CEC4Q41500735-B73D9577-04E7-4427-A8C7-56BB32271C1EQ42141880-AE58DBE8-BB35-4D3F-BFD1-02DF4F7A6B16Q45925882-6AB45A69-EC97-49C1-A44A-5FB30548F4E2Q47312597-63B7699B-C1AF-47B1-B374-FDED3EAEBCCBQ52695014-092D9B05-7A02-4A14-9D5D-BC5199829282Q57123140-E4BC706B-6D16-47CA-AE11-CC9D42EFE058
P2860
Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ertapenem administered as outp ...... ucing Gram-negative organisms.
@en
Ertapenem administered as outp ...... ucing Gram-negative organisms.
@nl
type
label
Ertapenem administered as outp ...... ucing Gram-negative organisms.
@en
Ertapenem administered as outp ...... ucing Gram-negative organisms.
@nl
prefLabel
Ertapenem administered as outp ...... ucing Gram-negative organisms.
@en
Ertapenem administered as outp ...... ucing Gram-negative organisms.
@nl
P356
P1476
Ertapenem administered as outp ...... ducing Gram-negative organisms
@en
P2093
Ann L N Chapman
Trevor G Winstanley
P304
P356
10.1093/JAC/DKQ152
P407
P50
P577
2010-05-11T00:00:00Z